Literature DB >> 31357078

A polymorphism in the IL1B gene (rs16944 T/C) is associated with cutaneous leishmaniasis caused by Leishmania guyanensis and plasma cytokine interleukin receptor antagonist.

George Allan Villarouco da Silva1, Tirza Gabrielle Ramos de Mesquita2, Helia Valeria de Souza Encarnação2, José do Espírito Santo Junior1, Karolina da Costa Sabino2, Isaac de Aguiar Neres2, Salim Assad de Almeida3, Mara Lúcia Gomes de Souza2, Sinésio Talhari4, Rajendranath Ramasawmy5.   

Abstract

Nod-like Receptor Protein3 (NLRP3) inflammasome in macrophages infected with Leishmania sp. enhances the secretion of IL-1β. Excess IL-1β production is linked to disease severity in patients with cutaneous leishmaniasis (CL) caused by L. mexicana. Blockade of the NLRP3 inflammasome in cell cultures from skin biopsies of patients with CL caused by L. braziliensis inhibited the release of IL-1β. We hypothesized that common single nucleotide polymorphisms in the IL1B and in its receptor antagonist IL1RN genes may be predictive of CL caused by L. guyanensis. The SNPs -511T/C (rs16944) and +3954C/T (rs1143634) of the IL1B and IL1RN VNTR (rs2234663) were assessed in 881 patients with CL and 837 healthy controls by PCR-RFLP and direct PCR respectively. Plasma cytokines levels were also assayed. The plasma levels of IL-1β were higher in patients compared to control subjects. In contrast, increased plasma levels of IL-1Ra were observed in controls. The rs16944 C/C genotype was more common among the patients (OR = 1.5 [95%CI 1.1-2.0]; P = 0.004) and the C allele suggests susceptibility to CL (OR = 1.2 [95%CI 1.1-1.4]; P = 0.003). The rs16944 C/C genotype shows a tendency to correlate with lower levels of the IL-1Ra cytokine. Low levels of IL-1Ra cytokine and rs16944 C/C genotype seem to confer susceptibility to L. guyanensis-infection in the Amazonas.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amazonas; Cutaneous Leishmaniasis; Leishmania guyanensis; Single nucleotide polymorphism, Interleukin-1 beta and Interleukin-1 receptor antagonist

Year:  2019        PMID: 31357078     DOI: 10.1016/j.cyto.2019.154788

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  TREM1 rs2234237 (Thr25Ser) Polymorphism in Patients with Cutaneous Leishmaniasis Caused by Leishmania guyanensis: A Case-Control Study in the State of Amazonas, Brazil.

Authors:  José do Espírito Santo Júnior; Tirza Gabrielle Ramos de Mesquita; Luan Diego Oliveira da Silva; Felipe Jules de Araújo; Josué Lacerda de Souza; Thaís Carneiro de Lacerda; Lener Santos da Silva; Cláudio Marcello da Silveira Júnior; Krys Layane Guimarães Duarte Queiroz; Diogo Matos Dos Santos; Cilana Chagas da Silva; Héctor David Graterol Sequera; Melissa Tamayo Hermida; Mara Lúcia Gomes de Souza; Marcus Vinitius de Farias Guerra; Rajendranath Ramasawmy
Journal:  Pathogens       Date:  2021-04-20

2.  Variants of MIRNA146A rs2910164 and MIRNA499 rs3746444 are associated with the development of cutaneous leishmaniasis caused by Leishmania guyanensis and with plasma chemokine IL-8.

Authors:  Tirza Gabrielle Ramos de Mesquita; José do Espírito Santo Junior; Thais Carneiro de Lacerda; Krys Layane Guimarães Duarte Queiroz; Cláudio Marcello da Silveira Júnior; José Pereira de Moura Neto; Lissianne Augusta Matos Gomes; Mara Lúcia Gomes de Souza; Marcus Vinitius de Farias Guerra; Rajendranath Ramasawmy
Journal:  PLoS Negl Trop Dis       Date:  2021-09-20

Review 3.  The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs).

Authors:  Payam Behzadi; Aga Syed Sameer; Saniya Nissar; Mujeeb Zafar Banday; Márió Gajdács; Herney Andrés García-Perdomo; Kulsum Akhtar; Marina Pinheiro; Peter Magnusson; Meysam Sarshar; Cecilia Ambrosi
Journal:  J Immunol Res       Date:  2022-03-26       Impact factor: 4.818

4.  Distinct plasma chemokines and cytokines signatures in Leishmania guyanensis-infected patients with cutaneous leishmaniasis.

Authors:  Tirza Gabrielle Ramos de Mesquita; José do Espírito Santo Junior; Luan Diego Oliveira da Silva; George Allan Villarouco Silva; Felipe Jules de Araújo; Suzana Kanawati Pinheiro; Herllon Karllos Athaydes Kerr; Lener Santos da Silva; Luciane Macedo de Souza; Samir Assad de Almeida; Krys Layane Guimarães Duarte Queiroz; Josué Lacerda de Souza; Cilana Chagas da Silva; Héctor David Graterol Sequera; Mara Lúcia Gomes de Souza; Anderson Nogueira Barbosa; Gemilson Soares Pontes; Marcus Vinitius de Farias Guerra; Rajendranath Ramasawmy
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.